Zions Bancorporation National Association UT Purchases 1,524 Shares of Synopsys, Inc. $SNPS

Zions Bancorporation National Association UT raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 17.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,495 shares of the semiconductor company’s stock after buying an additional 1,524 shares during the period. Zions Bancorporation National Association UT’s holdings in Synopsys were worth $5,381,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of SNPS. Brighton Jones LLC grew its position in Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after acquiring an additional 50 shares during the last quarter. Valeo Financial Advisors LLC boosted its stake in shares of Synopsys by 6.3% during the first quarter. Valeo Financial Advisors LLC now owns 570 shares of the semiconductor company’s stock valued at $244,000 after purchasing an additional 34 shares during the period. LBP AM SA bought a new position in shares of Synopsys in the first quarter worth about $318,000. Allworth Financial LP grew its holdings in shares of Synopsys by 3.1% in the first quarter. Allworth Financial LP now owns 2,499 shares of the semiconductor company’s stock worth $1,097,000 after purchasing an additional 74 shares during the last quarter. Finally, Alps Advisors Inc. increased its stake in Synopsys by 45.8% in the 1st quarter. Alps Advisors Inc. now owns 4,058 shares of the semiconductor company’s stock worth $1,740,000 after buying an additional 1,275 shares during the period. Institutional investors own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SNPS. Stifel Nicolaus lowered their price objective on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. KeyCorp lowered their price target on Synopsys from $660.00 to $590.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Citigroup downgraded Synopsys from a “neutral” rating to an “underperform” rating in a report on Wednesday, September 10th. Rosenblatt Securities reaffirmed a “neutral” rating and set a $605.00 target price (down from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, BNP Paribas began coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, Synopsys has an average rating of “Hold” and a consensus target price of $569.67.

Synopsys Stock Performance

Shares of NASDAQ:SNPS opened at $393.43 on Friday. The firm has a 50 day moving average of $475.14 and a 200 day moving average of $514.87. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $73.08 billion, a price-to-earnings ratio of 30.88, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm’s revenue was up 14.0% compared to the same quarter last year. During the same period last year, the business posted $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the transaction, the chief financial officer owned 15,317 shares in the company, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert G. Painter bought 350 shares of the stock in a transaction on Thursday, September 11th. The stock was purchased at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the purchase, the director owned 2,291 shares of the company’s stock, valued at $974,683.04. This represents a 18.03% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have sold 30,894 shares of company stock worth $16,760,783 over the last ninety days. 0.62% of the stock is currently owned by company insiders.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.